(Q32056571)

6 July 2017

title

Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects (English)

1 reference

6 July 2017

L A Sechi

1

1 reference

6 July 2017

S De Marchi

series ordinal

2

1 reference

6 July 2017

publication date

1 January 2001

1 reference

Journal of Investigative Medicine

6 July 2017

published in

1 reference

6 July 2017

volume

49

1 reference

6 July 2017

issue

1

1 reference

6 July 2017

page(s)

12-20

1 reference

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

The mysteries of lipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

The apolipoprotein(a) gene resides on human chromosome 6q26?27, in close proximity to the homologous gene for plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Lipoprotein(a) in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

A potential basis for the thrombotic risks associated with lipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Insulin hypersecretion: a distinctive feature between essential and secondary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Lipoprotein (a), low-density, intermediate-density lipoprotein, and blood pressure in a young male population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Plasma lipids and lipoproteins and essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Lipoprotein (a). Heterogeneity and biological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Haemostasis balance disorders in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

Detection and relevance of crosslinked fibrin derivatives in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34086

21 January 2018

Identifiers

DOI

10.2310/6650.2001.34086

1 reference

6 July 2017

1 reference